{
  "id": "mhgap#risk_safety_2c13c779",
  "content": "and methamphetamine.\nthat bupropion can potentially worsen treatment\ny In adults with cocaine dependence, compared with\nretention due to adverse effects (very low certainty).\nno treatment or treatment as usual (TAU), there is\ny Despite presence of some evidence of effectiveness\ninconsistent or no evidence for effectiveness of:\nof topiramate, prescription amphetamines/\nnaltrexone (very low certainty), modafinil (low to\ndexamphetamine and bupropion, it was decided\nvery low certainty), methylphenidate (very low\nnot to recommend their use due to limited data\nto moderate certainty) or mirtazapine (very low\non effectiveness, safety and absence of studies in\ncertainty) in terms of reducing drug use, promoting\nnon-specialized settings.\nabstinence, reducing harm from drug use or\nimproving retention to treatment. y Some medicines might have severe side effects and\nhave potential for abuse (such as dexamphetamines,\ny In adults with stimulant dependence, compared\nmethylphenidate, modafinil) and require careful\nwith no treatment or TAU, there is controversial or\nmonitoring, which might be difficult to achieve in\nno evidence for effectiveness of use of topiramate\nnon-specialized settings; their use should therefore\n(low to moderate certainty); naltrexone (low to very\nbe discouraged.\nlow certainty); modafinil (low certainty); prescription\n67",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety and methamphetamine.\nthat bupropion can potentially worsen treatment\ny In adults with cocaine dependence, compared with\nretention due to adverse effects (very low certainty).\nno treatment or treatment as usual (TAU), there is\ny Despite presence of some evidence of effectiveness\ninconsistent or no evidence for effectiveness of:\nof topiramate, prescription amphetamines/\nnaltrexone (very low certainty), modafinil (low to\ndexamphetamine and bupropion, it was decided\nvery low certainty), methylphenidate (very low\nnot to recommend their use due to limited data\nto moderate certainty) or mirtazapine (very low\non effectiveness, safety and absence of studies in\ncertainty) in terms of reducing drug use, promoting\nnon-specialized settings.\nabstinence, reducing harm from drug use or\nimproving retention to treatment. y Some medicines might have severe side effects and\nhave potential for abuse (such as dexamphetamines,\ny In adults with stimulant dependence, compared\nmethylphenidate, modafinil) and require careful\nwith no treatment or TAU, there is controversial or\nmonitoring, which might be difficult to achieve in\nno evidence for effectiveness of use of topiramate\nnon-specialized settings; their use should therefore\n(low to moderate certainty); naltrexone (low to very\nbe discouraged.\nlow certainty); modafinil (low certainty); prescription\n67 And methamphetamine. that bupropion can potentially worsen treatment\ny in adults with cocaine dependence, compared with\nretention due to adverse effects (very low certainty)."
}